Recent Research Explores the Global Transcatheter aortic valve replacement (TAVR) Market 2022

Infinium Global Research has added a new report on Global Transcatheter aortic valve replacement (TAVR) Market. The report predicts the market size of Transcatheter aortic valve replacement (TAVR) is expected to reach XX billion by 2022

Some of the key driving factors attributing to the growth of this market include increasing number of patients with cardiovascular diseases such as hypertension, heart failures and coronary artery diseases. In addition, increasing adoption of minimally invasive procedures over traditional surgical open-heart procedures, reduction in hospital stays, low risk of infection, minimal blood loss are further propelling the market. According to World Health Organization (WHO), it has been estimated that the number of people suffering from cardiovascular diseases will increase to 22.2 million by 2030. The market for TAVR is expected to reach around USD 6.5 billion by 2022, growing at a CAGR of 21.3% during the forecast period of 2016e to 2022f. However, there are certain restraining factors which could hamper the growth of this market, which includes, high costs associated with the LAVD implantation compared to other therapies available for CVD diseases. A TAVR device costs USD 30,000, which is six times the price of the average surgical valve. In addition, for a hospital to be reimbursed for a TAVR procedure, the patient must be evaluated by a multidisciplinary team that involves multiple cardiac surgeons and interventional cardiologists. However, there are some cost savings compared to surgery, such as shorter length of stay in the hospital.

Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness about minimally invasive surgical procedures among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.

Companies profiled:

  • Edwards Life Sciences Corp.
  • Boston Scientific Corp.
  • Direct Flow medical, Inc.
  • Bracco SpA.
  • JenaValve Technology, Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Jude Medical, Inc.
  • Transcatheter Technologies GmbH.

Key Topics Covered:

  1. Scope of the report
  2. Executive summary
  3. Qualitative analysis
  4. Global TAVR market, by type of treatment, 2014 – 2022
  5. Global TAVR market, by geography, 2014 – 2022
  6. Company profiles

Click below to access full report @ http://bit.ly/2slMPgN